Patents by Inventor Joseph J. Park

Joseph J. Park has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240120736
    Abstract: A control system may include a direct-current (DC) power bus for charging (e.g., trickle charging) internal energy storage elements in control devices of the control system. For example, the control devices may be motorized window treatments configured to adjust a position of a covering material to control the amount of daylight entering a space. The system may include a DC power supply that may generate a DC voltage on the DC power bus. For example, the DC power bus may extend from the DC power supply around the perimeter of a floor of the building and may be connected to all of the motorized window treatments on the floor (e.g., in a daisy-chain configuration). Wiring the DC power bus in such a manner may dramatically reduce the installation labor and wiring costs of an installation, as well as decreasing the chance of a miswire.
    Type: Application
    Filed: December 18, 2023
    Publication date: April 11, 2024
    Applicant: Lutron Technology Company LLC
    Inventors: Edward J. Blair, John H. Bull, Samuel F. Chambers, Stuart W. DeJonge, Joseph R. Parks
  • Patent number: 6649744
    Abstract: This invention relates to a novel bacterial ribonucleoprotein complex and the component parts thereof. More specifically, this invention relates to RNase P RNA isolated from Staphylococcus aureus and the use of RNase P RNA in screens for the identification of antimicrobial compounds and to the use of such compounds in therapy.
    Type: Grant
    Filed: November 5, 2001
    Date of Patent: November 18, 2003
    Assignees: SmithKline Beecham Corporation, SmithKline Beecham P.L.C.
    Inventors: Michael J. Gress, Lisa A Hegg, Hu Li, Joseph J. Park
  • Publication number: 20030191083
    Abstract: This invention relates to a novel bacterial ribonucleoprotein complex and the component parts thereof. More specifically, this invention relates to RNase P RNA isolated from Staphylococcus aureus and the use of RNase P RNA in screens for the identification of antimicrobial compounds and to the use of such compounds in therapy.
    Type: Application
    Filed: April 15, 2003
    Publication date: October 9, 2003
    Applicants: SmithKline Beecham Corporation, SmithKline Beecham p.l.c.
    Inventors: Michael J. Gress, Lisa A. Hegg, Hu Li, Joseph J. Park